Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-31
2011-12-27
Spivack, Phyllis G. (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08084491
ABSTRACT:
The subject invention provides methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising topiramate. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury.
REFERENCES:
patent: 892088 (1908-06-01), Rich
patent: 4513006 (1985-04-01), Maryanoff et al.
patent: 5384327 (1995-01-01), Costanzo et al.
patent: 5498629 (1996-03-01), Costenzo et al.
patent: 5507775 (1996-04-01), Ger et al.
patent: 5512041 (1996-04-01), Bogart
patent: 5512291 (1996-04-01), Li
patent: 5519020 (1996-05-01), Smith et al.
patent: 5520926 (1996-05-01), Ferguson
patent: 5522794 (1996-06-01), Ewall
patent: 5525335 (1996-06-01), Kitahara et al.
patent: 5571521 (1996-11-01), Lasker
patent: 5578022 (1996-11-01), Scherson et al.
patent: 5578310 (1996-11-01), M'Timkulu et al.
patent: 5602183 (1997-02-01), Martin et al.
patent: 5603946 (1997-02-01), Constantine
patent: 5610148 (1997-03-01), Brown
patent: 5614561 (1997-03-01), Martin
patent: 5629292 (1997-05-01), Rodgers et al.
patent: 5631019 (1997-05-01), Marx
patent: 5632727 (1997-05-01), Tipton et al.
patent: 5633285 (1997-05-01), Martin
patent: 5641814 (1997-06-01), Martin
patent: 5646190 (1997-07-01), Martin
patent: 5648380 (1997-07-01), Martin
patent: 5652274 (1997-07-01), Martin
patent: 5654461 (1997-08-01), Choi et al.
patent: 5658956 (1997-08-01), Martin et al.
patent: 5658957 (1997-08-01), Martin
patent: 5662904 (1997-09-01), Ferguson et al.
patent: 5662924 (1997-09-01), Rhodes
patent: 5663208 (1997-09-01), Martin
patent: 5667501 (1997-09-01), Fowler et al.
patent: 5674912 (1997-10-01), Martin
patent: 5685834 (1997-11-01), Barth
patent: 5690795 (1997-11-01), Rosenstein et al.
patent: 5692302 (1997-12-01), Martin et al.
patent: 5705477 (1998-01-01), Sporn et al.
patent: 5707647 (1998-01-01), Dunn et al.
patent: 5713842 (1998-02-01), Kay
patent: 5716337 (1998-02-01), McCabe et al.
patent: 5716935 (1998-02-01), Rodgers et al.
patent: 5735812 (1998-04-01), Kardy
patent: 5753694 (1998-05-01), Shank
patent: 5759570 (1998-06-01), Arnold
patent: 5760006 (1998-06-01), Shank et al.
patent: 5780048 (1998-07-01), Lee
patent: 5804213 (1998-09-01), Rolf
patent: 5807300 (1998-09-01), Nix, Jr.
patent: 5807341 (1998-09-01), Heim
patent: 5834432 (1998-11-01), Rodgers et al.
patent: 5856245 (1999-01-01), Caldwell et al.
patent: 5856364 (1999-01-01), Martin
patent: 5863938 (1999-01-01), Martin
patent: 5874479 (1999-02-01), Martin
patent: 5876743 (1999-03-01), Ibsen et al.
patent: 5892088 (1999-04-01), Choi et al.
patent: 5897516 (1999-04-01), Kadash et al.
patent: 5902600 (1999-05-01), Woller et al.
patent: 5914125 (1999-06-01), Andrews et al.
patent: 5955430 (1999-09-01), Rodgers et al.
patent: 5960795 (1999-10-01), Schultz
patent: 5968001 (1999-10-01), Freeman
patent: 5972332 (1999-10-01), Rees et al.
patent: RE36370 (1999-11-01), Li
patent: 5977428 (1999-11-01), Bozigian et al.
patent: 5981606 (1999-11-01), Martin
patent: 5989577 (1999-11-01), Hoath et al.
patent: 5998692 (1999-12-01), Gilding
patent: 6022556 (2000-02-01), Hardy
patent: 6025150 (2000-02-01), Livant
patent: 6033684 (2000-03-01), Norcia
patent: 6051249 (2000-04-01), Samuelsen
patent: 6071537 (2000-06-01), Shank
patent: 6087549 (2000-07-01), Flick
patent: 6093388 (2000-07-01), Ferguson
patent: 6096709 (2000-08-01), Rodgers et al.
patent: 6124273 (2000-09-01), Drohan et al.
patent: 6132759 (2000-10-01), Schacht et al.
patent: 6136341 (2000-10-01), Petito
patent: 6142982 (2000-11-01), Hunt et al.
patent: 6143037 (2000-11-01), Goldstein et al.
patent: 6323236 (2001-11-01), McElroy
patent: 6462084 (2002-10-01), Dewey et al.
patent: 6583172 (2003-06-01), Shank
patent: 2002/0082222 (2002-06-01), Shapira et al.
patent: 2002/0137903 (2002-09-01), Ellsworth et al.
patent: 2004/0014681 (2004-01-01), Ryback
patent: 0138441 (1984-09-01), None
patent: WO 98/00123 (1998-01-01), None
patent: WO 98/00129 (1998-01-01), None
patent: WO 98/00131 (1998-01-01), None
patent: WO 98/15270 (1998-04-01), None
patent: WO 00/00130 (2000-01-01), None
patent: WO 00/10610 (2000-03-01), None
patent: WO 00/23059 (2000-04-01), None
patent: WO 00/28945 (2000-05-01), None
patent: WO 00/44374 (2000-08-01), None
patent: WO 00/48549 (2000-08-01), None
patent: WO 00/50020 (2000-08-01), None
patent: WO 00/76493 (2000-12-01), None
patent: WO 02/43731 (2002-06-01), None
The Merck Manual, 17thedition (1999), p. 1938.
Stedman's Medical Dictionary (1995), p. 900.
Burton, L. and Harden, C., “Effect of Topiramate on Attention,”Epilepsy Research, 1997, pp. 29-32, vol. 27, Pub: Elsevier Science B.V.
Carrel, Al., et al., “Growth Hormone Improves Body Composition, Fat Utilization, Physical Strength and Agility, and Growth in Prader-Willi Syndrome: A Controlled Study,”J. Pediatrics, 1999, pp. 215-221, vol. 134, Pub: Mosby, Inc.
Crawford, P., “An Audit of Topiramate Use in a General Neurology Clinic,”Seizure, 1998, pp. 207-211, vol. 7, Pub: British Epilepsy Association.
Davanzo, P.A. and King, B.H., “Open Trial of Lamotrigine in the Treatment of Self-Injurious Behavior in an Adolescent with Profound Mental Retardation,”J. of Child&Adolescent Psychopharmacology, 1996, pp. 273-279, vol. 6, No. 4, Pub: Mary Ann Liebert, Inc.
Donovan, S.J., et al., “Divalproex Treatment for Youth with Explosive Temper and Mood Lability: A Double-Blind, Placebo-Controlled Crossover Design,”Am J Psychiatry, 2000, pp. 818-820, vol. 157, No. 5, Pub: Unknown.
Dykens, E.M. and Hodapp, R.M., “Treatment Issues in Genetic Mental Retardation Syndromes,”Professional Psychology: Research&Practice, 1997, pp. 263-270, vol. 28, No. 3, Pub: American Psychological Association, Inc.
Emerson, E., et al., “The Prevalence of Challenging Behaviors: A Total Population Study,”Res. In Developmental Disabilities, 2001, pp. 77-93, vol. 22, Pub: Elsevier Science Ltd.
Faught, E., et al., “Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory Partial Epilepsy Using 200-, 400-, and 600-mg Daily Dosages,”Neurology, 1996, pp. 1684-1690, vol. 46, Pub: American Academy of Neurology.
Gerber, P.E., et al., “Factors Associated with Behavioral and Cognitive Abnormalities in Children Receiving Topiramate,”Pediatric Neurology, 2000, pp. 200-203, vol. 22, No. 3, Pub: Elsevier Science Inc.
Glenn, C.C., et al., “Genomic Imprinting: Potential Function and Mechanisms Revealed by the Prader-Willi and Angelman Syndromes,”Molecular Human Reproduction, 1997, pp. 321-332, vol. 3, No. 4, Pub: European Society for Human Reproduction and Embryology.
Goldsmith, T., et al., “Conceptual Foundations of Obsessive-Compulsive Spectrum Disorders,”Obsessive-Compulsive Disorder: Theory, Research, and Treatment, 1998, pp. 397-425, Part III, Ch. 17, Pub: The Guilford Press, New York London, Div. Of Guilford Publications, Inc. (eds. Swinson, R.P., et al.), New York.
Gupta, B.K., et al., “Carbamazepine for Intermittent Explosive Disorder in a Prader-Willi Syndrome Patient,”J Clin Psychiatry, 1987, p. 423, vol. 48, No. 10, Pub: Unknown.
Haller, R. And Hinterhuber, H., “Treatment of Pathological Gambling with Carbamazepine,”Pharmacopsychiatry, 1994, p. 129, vol. 27, No. 3, Pub: Georg Thieme Verlag Stuttgart, New York.
Ireland, J.L., “A Descriptive Analysis of Self-Harm Reports Among a Sample of Incarcerated Adolescent Males,”J. Adolescence, 2000, pp. 605-613, vol. 23, Pub: Association for Professionals in Services for Adolescents.
Jones, M.W., “Topiramate—Safety and Tolerability,”Can. J. Neural. Sci., 1998, pp. S13-S15, vol. 25, Suppl. 3, Pub: Unknown, Canada.
Kmetz, G.F., et al., “Response of Kleptomania and Mixed Mania to Valproate,”Am J Psychiatry, 1997, pp. 580-581, vol. 154, No. 4, Pub: Unknown.
Ko, S.M., “Under-Diagnosed Psychiatric Syndrome II: Pathologic Skin Picking,”Annals Academy of Medicine Singapore, 1999, pp. 557-559,
Driscoll Daniel John
Lessig Mary Catherine
Shapira Nathan Andrew
Novodermix International Limited
Spivack Phyllis G.
LandOfFree
Treatments for wound healing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatments for wound healing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatments for wound healing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4314028